CI stock · FDMT stock

CI vs FDMT

Cigna Corp (CI) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.

Cigna Corp (CI) is a healthcare plans company listed on US.

4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.

Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.

Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.

CI currently screens at market cap $71.62B and trailing P/E 2.4. FDMT currently screens at market cap $518.1M.

Not investment advice. Open the CI and FDMT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons